Zoekresultaten - 26 results
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
those associated with vaccine HPV types and any cervical precancer. Exposure groups were: women aged: 15-26 or 24-45 years being initially negative for high-risk HPV (hrHPV) or negative for the vaccine ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
specificity of 1.00 (95% CI, 0.99 to 1.01) (value of >0.05 in all cases). Regardless of the clinical outcome (CIN2 + or CIN3 +), age restriction (women ≥30 years old), or comparator test used, Anyplex ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Publication Type: Peer reviewed scientific article Authors: Akbari, Ajmal; Vanden Broeck, Davy; Benoy, Ina; Padalko, Elizaveta; Bogers, Johannes; M. Arbyn Source: Virol J, Volume 15, Issue 1 (2018) ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; E Peeters; I Benoy; D Vanden Broeck; J Bogers; P De Sutter; G Donders; W Tjalma; S Weyers; Cuschieri, K; Poljak, M; J Bonde; ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
assessment, we considered it as high-risk (hr) HPV positive when at least one of the following HPV types was present: HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, and ...
Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.
Publication Type: Peer reviewed scientific article Authors: Clarke, Megan A; Long, Beverly J; Del Mar Morillo, Arena; M. Arbyn; Bakkum-Gamez, Jamie N; Wentzensen, Nicolas Source: JAMA Intern Med, ...
The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research
multidisciplinary consultation (MOC) in 2011. RESULTS: By the end of follow-up, 24 % of the workers were deceased. Among those who survived 26 % are unable to work, 12 % are unemployed and 63 % do not receive any ...
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.
Publication Type: Peer reviewed scientific article Authors: Östensson, Ellinor; Alder, Susanna; K Miriam Elfström; Sundström, Karin; Zethraeus, Niklas; M. Arbyn; Andersson, Sonia Source: PLoS One, ...
Early effects of human papillomavirus vaccination in Belgium.
Publication Type: Peer reviewed scientific article Authors: Merckx, Mireille; Vanden Broeck, Davy; Benoy, Ina; Depuydt, Christophe; Weyers, Steven; M. Arbyn Source: Eur J Cancer Prev, Volume 24, ...
Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program.
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Castle, Philip E Source: Cancer Epidemiol Biomarkers Prev, Volume 24, Issue 5, p.769-72 (2015) Keywords: Female Humans Mass ...